Vivos (RDGL) Net Cash Flow (2010 - 2025)
Vivos' (RDGL) quarterly Net Cash Flow came in at -$540399.0 in Q4 2025, down 154.34% year-on-year from $994388.0 in Q4 2024, and down 17.87% quarter-over-quarter from -$458481.0 in Q3 2025.
Vivos (RDGL) Net Cash Flow (2010 - 2025) Analysis & Trends
Vivos has disclosed Net Cash Flow across 16 years of filings, most recently posting -$540399.0 for Q4 2025.
- Net Cash Flow for Q4 2025 came in at -$540399.0, down 154.34% year-over-year; the trailing twelve-month figure through Dec 2025 was -$550838.0 (down 188.81% YoY), and the FY2025 annual result was -$654023.0, down 205.44% from the prior year.
- Net Cash Flow came in at -$540399.0 for Q4 2025 at Vivos, down from -$458481.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $1.6 million in Q1 2021 to a low of -$604510.0 in Q2 2025.
- The 5-year median for Net Cash Flow is -$282320.5 (2022), against an average of -$55633.0.
- Across the five-year window, Net Cash Flow soared 10558.09% in 2021 and tumbled 270.96% in 2025, its largest moves.
- Vivos' Net Cash Flow stood at -$380468.0 in 2021, then gained by 25.97% to -$281667.0 in 2022, then soared by 119.68% to $55443.0 in 2023, then surged by 1693.53% to $994388.0 in 2024, then tumbled by 154.34% to -$540399.0 in 2025.
- The last three Net Cash Flow figures came in at -$540399.0 (Q4 2025), -$458481.0 (Q3 2025), and -$604510.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -159.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -282.15 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 202.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 20.30 Mn |
| 10 | Vivos | - | - | -3,105.00 | -540,399.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -540,399.00 |
| Dec 31, 2025 | -540,399.00 |
| Sep 30, 2025 | -458,481.00 |
| Sep 30, 2025 | -458,481.00 |
| Jun 30, 2025 | -604,510.00 |
| Jun 30, 2025 | -604,510.00 |
| Mar 31, 2025 | 1.05 Mn |
| Mar 31, 2025 | 1.05 Mn |
| Dec 31, 2024 | 994,388.00 |
| Dec 31, 2024 | 994,388.00 |
| Sep 30, 2024 | -506,257.00 |
| Sep 30, 2024 | -506,257.00 |
| Jun 30, 2024 | 353,588.00 |
| Jun 30, 2024 | 353,588.00 |
| Mar 31, 2024 | -221,458.00 |
| Mar 31, 2024 | -221,458.00 |
| Dec 31, 2023 | 55,443.00 |
| Dec 31, 2023 | 55,443.00 |
| Sep 30, 2023 | -211,923.00 |
| Sep 30, 2023 | -211,923.00 |